IBB looks to have a just broken out of a 5 year basing pattern. The longer the base, the higher in space. I'm going long 3-5 year hold with sell target of >$400.
Moderna (MRNA, $62) was one of top quarterly gainers, jumping +106.32% to $62 per share. Tickeron A.I.dvisor analyzed 380 stocks in the Biotechnology Industry over the last three months, and discovered that 357 of them (94.07%) charted an Uptrend while 23 of them (5.93%) trended down. Tickeron A.I.dvisor found 135 similar cases when MRNA's price jumped over 15%...
Link to Culper Research report that states they are shorting VBIV because the company is "worthless" img1.wsimg.com First, it's always important to consider ALL information. It's also important to be transparent about knowledge. If you are going to make any VBIV trades you really should read the entire report. 1) I think many of the points made in the Culper...
Tickeron AI shows that a buy signal is indicated by this change in price, due to the trend repositioning higher. In 2 of 2 cases where AVRO's 50-day Moving Average crossed above its 200-day Moving Average, its price rose further within the subsequent month. The odds of a continued Uptrend are 90%.
Just re-iterating my previous assertion (guess) that NVAX is on course for massive gains in the long-term. Doesn't mean it's a great company but this pandemic has initiated a similar pattern in the past. They have several great developments in the works: NanoFlu, RSV F, and a COVID-19 vaccine candidate. See my previous posts especially the related one. This is...
Over the last three days, Tickeron AI has detected that PFNX's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red line stays below 30, this is an indicator that the stock could be poised for a strong Uptrend. For traders, this could mean going long the stock or exploring call...
Five Prime Therapeutics (FPRX, $6.39) was one of top quarterly gainers, jumping +132.36% to $6.39 per share. Tickeron A.I.dvisor analyzed 380 stocks in the Biotechnology Industry over the last three months, and discovered that 356 of them (93.72%) charted an Uptrend while 24 of them (6.28%) trended down. Tickeron A.I.dvisor found 279 similar cases when FPRX's...
This is a Bullish indicator signaling KURA's price could rise from here. Traders may explore going long the stock or buying call options. I identified 47 similar cases where KURA's MACD histogram became positive, and 39 of them led to successful outcomes. Odds of Success: 83%.
This is a Bullish indicator signaling IONS's price could rise from here. Traders may explore going long the stock or buying call options. I identified 40 similar cases where IONS's MACD histogram became positive, and 35 of them led to successful outcomes. Odds of Success: 88%.
This is a Bullish indicator signaling KURA's price could rise from here. Traders may explore going long the stock or buying call options. I identified 47 similar cases where KURA's MACD histogram became positive, and 39 of them led to successful outcomes. Odds of Success: 83%.
This indicator may be signaling that CBAY's price has momentum to move higher, since its current price exceeds the price logged 14 days ago. Traders may consider buying the stock or exploring call options. I backtested 91 similar cases where CBAY's Momentum Indicator exceeded 0, and 78 of them led to a successful outcome. Odds of Success: 86%.
Another descending triangle has appeared in LABD. My numerous other finds have yielded decent results but we have yet to see a turn in the market indicating a new direction. The play itself might be worth a couple of percent gain but please trade safely. The downturn near the end of Friday's session is forecasting a likely poor Monday opening in addition to the...
A buy signal is generated. This is a Bullish indicator signaling ACAD's price could rise from here. Traders may explore going long the stock or buying call options. I identified 45 similar cases where ACAD's MACD histogram became positive, and 38 of them led to successful outcomes. Odds of Success: 84%.
This price move could indicate a change in the trend, and may be a buy signal for investors.I found 43 similar cases, and 43 were successful. Based on this data, the odds of success are 90%.
A buy signal is generated. This price move could indicate a change in the trend and may be a buy signal for investors. I found 43 similar cases, and 43 were successful. Based on this data, the odds of success are 90%.
All description on the chart. Please, don't forget to like and follow. Thank you.
Analyst forecasts for Merck earnings came down sharply early this year, but lately they've stabilized and even ticked upward a little. Merck is still priced for an optimistic market, with forward P/E around 15 and PEG around 2-3. This is reasonable for a large cap company with 3% dividend and a great reputation, but it's not bargain pricing, exactly. A second...